Validation of quality indicators for radical prostatectomy

International Journal of Cancer. Journal International Du Cancer
Ellen O M ChanD Robert Siemens

Abstract

The feasibility and validity of proposed radical prostatectomy quality indicators has not been well studied. We assessed indicator availability from treating charts. We tested the convergent construct validity of a modified subset that were available from this information source by correlating them to hospital prostatectomy volume, a variable repeatedly associated with the quality of surgical care. The study population consisted of a stratified random sample of prostate cancer patients who were: (i) diagnosed between 1990 and 1998 in Ontario and (ii) treated by radical prostatectomy with curative intent within 6 months of diagnosis (n = 645). Of the 9 candidate quality indicators assessed, 4 were missing for 25-56% of study subjects and were not analyzed further. We discuss the implications of this missing information on feasibility of their use. For blood transfusions of 3 units or greater, length of hospital stay and use of non-nerve-sparing surgical technique, worse outcomes were generally apparent with decreasing hospital volume. Acute complication rates and positive surgical margin rates did not increase with decreasing hospital volume. We were able to demonstrate convergent construct validity for 3 quality indicators. Upo...Continue Reading

References

May 1, 1968·Journal of the American Geriatrics Society·B S LinnL Gurel
Apr 1, 1982·Scientific American·J Wennberg, A Gittelsohn
May 26, 1993·JAMA : the Journal of the American Medical Association·G L Lu-YaoJ E Wennberg
Nov 1, 1996·The Journal of Urology·J A EasthamP T Scardino
Feb 1, 1997·Cancer·J W RobinsonT S Fung
Jan 14, 1999·The Australian and New Zealand Journal of Surgery·M Z AnsariI G McDonald
Jul 20, 1999·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·M Z AnsariI G McDonald
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A V D'AmicoC N Coleman
Feb 25, 2000·The Journal of Urology·L M EllisonJ D Birkmeyer
Apr 21, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H Van PoppelUNKNOWN EORTC GU Group
Oct 10, 2001·The Urologic Clinics of North America·B ShekarrizD P Wood
Apr 12, 2002·The New England Journal of Medicine·Colin B BeggPeter T Scardino
Feb 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jim C HuMark S Litwin
Feb 5, 2003·European Urology·E J H Meuleman, P F A Mulders
Mar 12, 2003·The Journal of Urology·Jim C HuMark S Litwin
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin A SpencerMark S Litwin
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony V D'AmicoMing-Hui Chen
Jun 6, 2003·Cancer Treatment Reviews·Kate D Linton, Freddie C Hamdy
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E BauvinP Grosclaude
May 10, 2005·The Journal of Urology·L M EllisonA W Partin
Jul 12, 2005·The Journal of Urology·David C MillerJohn T Wei
Jul 12, 2005·The Journal of Urology·Fadi N Joudi, Badrinath R Konety
Jul 19, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H Van PoppelS Joniau
Jul 28, 2005·Cancer·Tracey L KrupskiMark S Litwin
Sep 20, 2005·TheScientificWorldJournal·Gerasimos Alivizatos, Andreas Skolarikos
Oct 20, 2005·Journal of the National Cancer Institute·Shabbir M H AlibhaiGary Naglie
Nov 30, 2006·Psychology, Health & Medicine·UNKNOWN The National Institute Of Mental Health Multisite HIV Prevention Trial Group
Apr 21, 2007·Medical Care·David C MillerMark S Litwin

❮ Previous
Next ❯

Citations

Jun 16, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·D Robert Siemens
Jun 16, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·D Robert Siemens
Jun 15, 2013·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Julie M DegrootPatti A Groome
Nov 6, 2012·The Journal of Urology·Arthur HartzChristopher Dechet
Apr 5, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Brita DanielsonWilliam Mackillop
Mar 17, 2010·American Journal of Infection Control·Renata Ferreira TakahashiMaria Clara Padoveze
Jun 9, 2016·Revista latino-americana de enfermagem·Talita Raquel Dos SantosAnna Luiza de Fátima Pinho Lins Gryschek
Jun 21, 2021·European Urology Focus·Guillaume PloussardUNKNOWN Comité de Cancérologie de l’Association Française d’Urologie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BMJ : British Medical Journal
Mike PringleRichard Grol
American Journal of Preventive Medicine
E A McGlynn, S M Asch
© 2022 Meta ULC. All rights reserved